awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34973750-B33A60F0-959E-4EC3-9F88-C835730C6663
Q34973750-B33A60F0-959E-4EC3-9F88-C835730C6663
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-B33A60F0-959E-4EC3-9F88-C835730C6663
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
P2860
Q34973750-B33A60F0-959E-4EC3-9F88-C835730C6663
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-B33A60F0-959E-4EC3-9F88-C835730C6663
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e47669c8a5140950c5e4e909466db5e8b77bbd2
P2860
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.